105 related articles for article (PubMed ID: 22144113)
1. Molecular mechanism of HIV-1 integrase-vDNA interactions and strand transfer inhibitor action: a molecular modeling perspective.
Xue W; Liu H; Yao X
J Comput Chem; 2012 Feb; 33(5):527-36. PubMed ID: 22144113
[TBL] [Abstract][Full Text] [Related]
2. Raltegravir flexibility and its impact on recognition by the HIV-1 IN targets.
Arora R; de Beauchene IC; Polanski J; Laine E; Tchertanov L
J Mol Recognit; 2013 Sep; 26(9):383-401. PubMed ID: 23836466
[TBL] [Abstract][Full Text] [Related]
3. Understanding the effect of drug-resistant mutations of HIV-1 intasome on raltegravir action through molecular modeling study.
Xue W; Qi J; Yang Y; Jin X; Liu H; Yao X
Mol Biosyst; 2012 Aug; 8(8):2135-44. PubMed ID: 22648037
[TBL] [Abstract][Full Text] [Related]
4. Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis.
Xue W; Jin X; Ning L; Wang M; Liu H; Yao X
J Chem Inf Model; 2013 Jan; 53(1):210-22. PubMed ID: 23231029
[TBL] [Abstract][Full Text] [Related]
5. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
[TBL] [Abstract][Full Text] [Related]
6. Strand transfer inhibitors of HIV-1 integrase: bringing IN a new era of antiretroviral therapy.
McColl DJ; Chen X
Antiviral Res; 2010 Jan; 85(1):101-18. PubMed ID: 19925830
[TBL] [Abstract][Full Text] [Related]
7. Constructing HIV-1 integrase tetramer and exploring influences of metal ions on forming integrase-DNA complex.
Wang LD; Liu CL; Chen WZ; Wang CX
Biochem Biophys Res Commun; 2005 Nov; 337(1):313-9. PubMed ID: 16188234
[TBL] [Abstract][Full Text] [Related]
8. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
9. HIV integrase as a target for antiviral chemotherapy.
Nair V
Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the integrase-DNA complex by Mg2+ ions and prediction of key residues for binding HIV-1 integrase inhibitors.
Miri L; Bouvier G; Kettani A; Mikou A; Wakrim L; Nilges M; Malliavin TE
Proteins; 2014 Mar; 82(3):466-78. PubMed ID: 24038133
[TBL] [Abstract][Full Text] [Related]
11. Study on the molecular mechanism of inhibiting HIV-1 integrase by EBR28 peptide via molecular modeling approach.
Hu JP; Gong XQ; Su JG; Chen WZ; Wang CX
Biophys Chem; 2008 Feb; 132(2-3):69-80. PubMed ID: 18037557
[TBL] [Abstract][Full Text] [Related]
12. Influence of Mg2+ on the binding modes of HIV-1 integrase with thiazolothiazepine inhibitor studied by molecular simulation.
Wang L
Comput Biol Med; 2009 Apr; 39(4):355-60. PubMed ID: 19268284
[TBL] [Abstract][Full Text] [Related]
13. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.
Li P; Tan JJ; Liu M; Zhang XY; Chen WZ; Wang CX
J Biomol Struct Dyn; 2011 Oct; 29(2):311-23. PubMed ID: 21875151
[TBL] [Abstract][Full Text] [Related]
14. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics studies of the full-length integrase-DNA complex.
De Luca L; Vistoli G; Pedretti A; Barreca ML; Chimirri A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1010-6. PubMed ID: 16165087
[TBL] [Abstract][Full Text] [Related]
16. Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling.
Liu M; Cong XJ; Li P; Tan JJ; Chen WZ; Wang CX
Biopolymers; 2009 Sep; 91(9):700-9. PubMed ID: 19382173
[TBL] [Abstract][Full Text] [Related]
17. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
[TBL] [Abstract][Full Text] [Related]
18. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
19. A quantum mechanics/molecular mechanics study of the protein-ligand interaction for inhibitors of HIV-1 integrase.
Alves CN; Martí S; Castillo R; Andrés J; Moliner V; Tuñón I; Silla E
Chemistry; 2007; 13(27):7715-24. PubMed ID: 17570717
[TBL] [Abstract][Full Text] [Related]
20. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
Voet AR; Maeyer MD; Debyser Z; Christ F
Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
